Dr Nicholas J Sarlis | CureTalks
Nicholas J. (Nick) Sarlis, MD, PhD, is a physician-scientist with deep experience in clinical and translational research in the areas of oncology and immunology. He is currently an Executive Medical Advisor for the Lynx Group, a global strategic alliance focused on medical and scientific communication and a Senior Advisor for SELLAS, a biotechnology company developing cancer vaccines. Previously, Nick was the Chief Medical Officer at SELLAS, and, before that, Head of Medical Affairs at Incyte Corporation, after having held senior positions at the Oncology Franchise at Sanofi (both in the US and France). He is a former Assoc. Professor at the MD Anderson Cancer Center, the largest cancer medical center in the world, and senior clinical investigator at the National Institutes of Health. He is a graduate of the University of Athens, Greece, for his MD, as well as the University of London for his PhD. He trained at the University of Utah, as well as at the National Institutes of Health. Over the years, Nick has managed portfolios for 6 anticancer drugs and contributed to the pipeline advancement and/or pharmacology of 21 compounds across 5 therapeutic areas. He is Assoc. Editor for the Journal of Translational Medicine, and perpetual reviewer for the European Cooperation in Science and Technology Program grants. Nick has published more than 135 papers and monographs mainly with a focus on novel treatments for cancer and has received various awards for his contributions to-date.
The second episode of CureTalks with Gary discusses new immunotherapies with Sellas Life Sciences. Talking to Gary Petersen is Dr Angelos M. Stergiou…